Myelodysplastic syndromes trials in New Zealand

4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

  Where

  Auckland

  Age

  18 years and over

  People

  210 worldwide

  Run by

  Takeda

  See details and how to joinNCT04419649 · EU 2023-507469-24-00
• Phase 1/2Taking people
  A Study of BGB-11417 in Participants With Myeloid Malignancies

  Where

  Auckland, Wellington

  Age

  18 years and over

  People

  260 worldwide

  Run by

  BeOne Medicines

  See details and how to joinNCT04771130 · EU 2023-508881-14-00
• Phase 1/2Taking people
  The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  Where

  Christchurch, Grafton

  Age

  Up to 22 years

  People

  960 worldwide

  Run by

  PedAL BCU, LLC

  See details and how to joinNCT04726241
• Phase 1/2Taking people
  Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia

  Where

  Grafton

  Age

  18 years and over

  People

  240 worldwide

  Run by

  Aptose Biosciences Inc.

  See details and how to joinNCT03850574 · EU 2023-503244-14-00